ALG11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.333600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.220400E-01
Normal-vs-Stage2
7.246600E-01
Normal-vs-Stage3
6.400000E-01
Normal-vs-Stage4
8.374200E-01
Stage1-vs-Stage2
7.612400E-01
Stage1-vs-Stage3
5.538400E-01
Stage1-vs-Stage4
8.620200E-01
Stage2-vs-Stage3
5.860400E-01
Stage2-vs-Stage4
9.611800E-01
Stage3-vs-Stage4
6.692200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.465600E-01
Normal-vs-AfricanAmerican
5.548600E-01
Normal-vs-Asian
5.712400E-01
Caucasian-vs-AfricanAmerican
7.486600E-01
Caucasian-vs-Asian
7.461800E-01
AfricanAmerican-vs-Asian
9.342000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.706800E-01
Normal-vs-Female
7.117000E-01
Male-vs-Female
7.820600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.626800E-01
Normal-vs-Age(41-60Yrs)
7.273800E-01
Normal-vs-Age(61-80Yrs)
6.386000E-01
Normal-vs-Age(81-100Yrs)
5.649400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.556600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.426000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.349400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.297800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.639000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.594000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.876200E-01
Normal-vs-Daily Drinker
6.953000E-01
Normal-vs-Weekly Drinker
8.970000E-01
Normal-vs-Occasional Drinker
5.898400E-01
Normal-vs-Social Drinker
8.667400E-01
Non Drinker-vs-Daily Drinker
5.515400E-01
Non Drinker-vs-Weekly Drinker
2.083800E-01
Non Drinker-vs-Occasional Drinker
5.925600E-01
Non Drinker-vs-Social Drinker
2.084600E-01
Daily Drinker-vs-Weekly Drinker
3.624000E-01
Daily Drinker-vs-Occasional Drinker
9.240400E-01
Daily Drinker-vs-Social Drinker
6.561000E-01
Weekly Drinker-vs-Occasional Drinker
3.455800E-01
Weekly Drinker-vs-Social Drinker
5.171600E-01
Occasional Drinker-vs-Social Drinker
5.382000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.201800E-01
Normal-vs-Grade 2
3.741000E-01
Normal-vs-Grade 3
2.745600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.047590E-01
Grade 1-vs-Grade 3
6.316400E-02
Grade 1-vs-Grade 4
7.201800E-01
Grade 2-vs-Grade 3
6.411800E-01
Grade 2-vs-Grade 4
3.741000E-01
Grade 3-vs-Grade 4
2.745600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.935600E-01
Normal-vs-NonDiabetic
6.805400E-01
Diabetic-vs-NonDiabetic
3.434800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.807000E-01
Normal-vs-NoPancreatitis
5.192400E-01
Pancreatitis-vs-NoPancreatitis
6.594500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.354400E-01
Normal-vs-N1
7.232400E-01
N0-vs-N1
4.095400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.833200E-01
Normal-vs-TP53-NonMutant
7.033600E-01
TP53-Mutant-vs-TP53-NonMutant
5.72690000000264E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
